FDA Plays

[newtostocks23]

I follow the progressions of $VVUS since I keep it on my watch list. I do believe that it will get the fda nod next time around however, Avanafil will be a dead on arrival product IMO unfortunately. The market is overcrowded with ED products including one by GSK/Merck called Staxyn last year which is IMO better then Avanafil.

If you want more info on VVUS I recommend you follow @TroKalayjian on twitter, he's big on em.

thanks bud